CLIPMERGE Pharmacogenetics Project
Today, patients at Mount Sinai can already benefit from personalized medicine. For example, with the CLIPMERGE Pharmacogenetics project BioMe participants undergoing routine care at Mount Sinai Medical Center consent to test their DNA for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. These results will be made available to the patient's treating physician at the time they are prescribing certain medications.
See detailed information and ways to participate